Slide background
INNOVATING targeting
Slide background
INNOVATING targeting

PHILOGEN

Is a Swiss-Italian biopharmaceutical company, which discovers and develops immunomodulatory antibody products for the therapy of cancer and of chronic inflammation.... Read all

NEWS

Philogen. Data from Phase Ib clinical trial of Dekavil in rheumatoid arthritis will be presented at the 4th Israel-Italy Meeting of Autoimmunity and Autoinflammation: Cutting Edge. Siena (Italy),...

Read all

PIPELINE

Philogen is a fully integrated company active in the discovery, GMP production and clinical development of immunomodulatory biopharmaceuticals. We have a leading position... Read all

PARTNERS

Pfizer
Abbvie
Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.